By: Sean Whooley
Supira Medical announced today that it began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD).
Sean Whooley is an Assistant Editor at MassDevice. He specializes in medicine and healthcare, covering topics such as diagnostics, alternative medicine, and legal affairs, while also reporting on business leaders and market trends. Sean's work has been featured in notable outlets including NewsBreak, The Robot Report, and Pharmaceutical Processing World.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Sean Whooley's articles predominantly focus on healthcare and pharmaceuticals, with a specific emphasis on medical technology, FDA approvals, medical devices, and the pharmaceutical industry. His coverage heavily features press releases and private sector announcements.
To effectively reach out to Sean, consider providing access to exclusive interviews or insights from key figures within the healthcare and pharmaceutical sectors. Additionally, offering in-depth analysis of new technologies or regulatory developments in the medical field could be particularly appealing to him. Given his interest in scientific themes as well, pitches related to cutting-edge research or technological advancements may also capture his attention.
This information evolves through artificial intelligence and human feedback. Improve this profile .